Format

Send to

Choose Destination
Rev Panam Salud Publica. 2015 Aug;38(2):163-6.

Paving pathways: Brazil's implementation of a national human papillomavirus immunization campaign.

Author information

1
Rollins School of Public Health, Emory University, Atlanta, Georgia, United States of America.
2
Emory University, Atlanta, Georgia, United States, DFigue2@emory.edu.
3
Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil.
4
Department of Preventive Medicine, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.

Abstract

In 2014, Brazil introduced an HPV immunization program for girls 9-13 years of age as part of the Unified Health System's (SUS) National Immunization Program. The first doses were administered in March 2014; the second ones, in September 2014. In less than 3 months more than 3 million girls received the first dose of quadrivalent HPV vaccine, surpassing the target rate of 80%. This paper examines three elements that may influence the program's long-term success in Brazil: sustaining effective outreach, managing a large technology-transfer collaboration, and developing an electronic immunization registry, with a focus on the State of São Paulo. If these three factors are managed, the Government of Brazil is primed to serve as a model of success for other countries interested in implementing a national HPV vaccination program to decrease HPV-related morbidity and mortality.

PMID:
26581058
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center